About AmniSure
AmniSure is a company based in Germantown (United States) founded in 2005 was acquired by Qiagen in May 2012. AmniSure operates in a competitive market with competitors including Natera, BillionToOne, SYNLAB, Progenity and Auxogyn, among others.
- Headquarter Germantown, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AmniSure
Detailed funding history for AmniSure
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AmniSure
AmniSure has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Products and reagents for molecular diagnostic assays are supplied.
|
Locked | Locked | Locked |
Investor details for AmniSure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AmniSure
Investment portfolio details for AmniSure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AmniSure
Detailed financials for AmniSure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amnisure Comparisons
Peer comparison for AmniSure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AmniSure
AmniSure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, SYNLAB, Progenity and Auxogyn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of cell-free cancer liquid biopsy test
|
|
| Locked | Locked | Locked |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for IVF embryo viability assessment are developed.
|
|
| Locked | Locked | Locked |
Sensitive multiplex platforms for QPCR are developed using toehold probes.
|
Detailed competitors of AmniSure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amnisure
Complete news archive for AmniSure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AmniSure
AmniSure was founded in 2005.
AmniSure is headquartered in Germantown, United States.
Michael Friedman is the current CEO of AmniSure.
AmniSure was founded in 2005 in Germantown, United States, and operates in the medical diagnostics sector focused on obstetrics. A proprietary test, the AmniSure ROM Test, is developed and marketed to identify premature rupture of fetal membranes through detection of the PAMG-1 protein marker in amniotic fluid. This addresses a condition affecting about 10 of pregnancies and 30 of preterm cases.
AmniSure's top competitors include Natera, BillionToOne and Overture Life.
AmniSure has 1 investor. Key investors include Qiagen.